Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model

Archives of Pharmacal Research

Volumn 32, Issue 5, 2009, Pages 781-787

  Kim, Hwan Mook ^b   Kang, Jong Soon ^b   Lim, Jaeseung ^c   Kim, Jee Youn ^a   Kim, Yeon Jin ^a   Lee, Soo Jae ^a   Song, Sukgil ^a   Hong, Jin Tae ^a   Kim, Youngsoo ^a   Han, Sang Bae ^a  

^a Chungbuk National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Innocell Ltd   (South Korea)

Author keywords

Adoptive immunotherapy; Cytokine induced killer cells; U 87 MG glioma

Indexed keywords

CD3 ANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CHROMIUM 51; INTERLEUKIN 2;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL LINE; CELL POPULATION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE INDUCED KILLER CELL; CYTOTOXICITY; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KILLER CELL; MOUSE; NONHUMAN; NUDE MOUSE; PERIPHERAL BLOOD MONONUCLEAR CELL; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; BRAIN TUMOR; CELL SURVIVAL; DRUG SCREENING; GLIOMA; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; PATHOLOGY; TIME; TRANSPLANTATION; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD56; ANTIGENS, CD8; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINE-INDUCED KILLER CELLS; GLIOMA; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; MICE; MICE, NUDE; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67649373027     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1518-1     Document Type: Article

References (33)

1. J. C. Alvarnas Y. C. Linn E. G. Hope R. S. Negrin 2001 Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation Biol. Blood Marrow Transplant. 7 216 222
2. R. O. Dillman C. M. Duma P. M. Schiltz C. DePriest R. A. Ellis K. Okamoto L. D. Beutel C. De Leon S. Chico 2004 Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma J. Immunother. 27 398 404
3. M. Edinger Y. A. Cao M. R. Verneris M. H. Bachmann C. H. Contag R. S. Negrin 2003 Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging Blood 101 640 648
4. R. A. Fenstermaker M. J. Ciesielski 2004 Immunotherapeutic strategies for malignant glioma Cancer Control 11 181 191
5. G. G. Gomez C. A. Kruse 2006 Mechanisms of malignant glioma immune resistance and sources of immunosuppression Gene Ther. Mol. Biol. 10 133 146
6. R. C. Grabert L. P. Cousens J. A. Smith S. Olson J. Gall W. B. Young P. A. Davol L. G. Lum 2006 Human T cells armed with Her2/neu bispecific antibodies divide, are cytotoxic, and secrete cytokines with repeated stimulation Clin. Cancer Res. 12 569 576
7. T. Gupta R. Sarin 2002 Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care Lancet Oncol. 3 557 564
8. R. L. Hayes M. Koslow E. M. Hiesiger K. B. Hymes H. S. Hochster E. J. Moore D. M. Pierz D. K. Chen G. N. Budzilovich J. Ransohoff 1995 Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma Cancer 76 840 852
9. F. P. Holladay T. Heitz G. W. Wood 1992 Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells J. Neurosurg. 77 757 762
10. S. K. Jacobs D. J. Wilson P. L. Kornblith E. A. Grimm 1986 In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes J. Neurosurg. 64 114 117
11. P. Kalinski Y. Nakamura P. Watchmaker A. Giermasz R. Muthuswamy R. B. Mailliard 2006 Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines Immunol. Res. 36 137 146
12. H. M. Kim J. S. Kang J. Lim S. K. Park K. Lee Y. D. Yoon C. W. Lee K. H. Lee G. Han K. H. Yang Y. J. Kim Y. Kim S. B. Han 2007 Inhibition of human ovarian tumor growth by cytokine-induced killer cells Arch. Pharm. Res. 30 1464 1470
13. H. M. Kim J. Lim S. K. Park J. S. Kang K. Lee C. W. Lee K. H. Lee M. J. Yun K. H. Yang G. Han S. W. Kwon Y. Kim S. B. Han 2007 Antitumor activity of cytokine-induced killer cells against human lung cancer Int. Immunopharmacol. 7 1802 1807
14. H. M. Kim J. Lim Y. D. Yoon J. M. Ahn J. S. Kang K. Lee S. K. Park Y. J. Jeong J. M. Kim G. Han K. H. Yang Y. J. Kim Y. Kim S. B. Han 2007 Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma Int. Immunopharmacol. 7 1793 1801
15. M. Kornacker G. Moldenhauer M. Herbst E. Weilguni F. Tita-Nwa C. Harter M. Hensel A. D. Ho 2006 Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gamma Int. J. Cancer 119 1377 1382
16. M. Lacroix D. Abi-Said D. R. Fourney Z. L. Gokaslan W. Shi F. DeMonte F. F. Lang I. E. McCutcheon S. J. Hassenbusch E. Holland K. Hess C. Michael D. Miller R. Sawaya 2001 A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J. Neurosurg. 95 190 198
17. H. Li J. P. Yu S. Cao F. Wei P. Zhang X. M. An Z. T. Huang X. B. Ren 2007 CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients J. Clin. Immunol. 27 317 326
18. P. H. Lu R. S. Negrin 1994 A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency J. Immunol. 153 1687 1696
19. R. M. Prins M. R. Graf R. E. Merchant 2001 Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis Cancer Immunol. Immunother. 50 285 292
20. C. Raja Gabaglia Y. Diaz de Durana F. L. Graham J. Gauldie E. E. Sercarz T. A. Braciak 2007 Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors Cancer Res. 67 2290 2297
21. X. Ren J. Yu H. Liu P. Zhang X. An N. Zhang X. Hao 2006 Th1 bias in PBMC induced by multicycles of auto-CIKs infusion in malignant solid tumor patients Cancer Biother. Radiopharm. 21 22 33
22. I. G. Schmidt-Wolf R. S. Negrin H. P. Kiem K. G. Blume I. L. Weissman 1991 Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity J. Exp. Med. 174 139 149
23. S. Sun X. M. Li X. D. Li W. S. Yang 2005 Studies on inducing apoptosis effects and mechanism of CIK cells for MGC-803 gastric cancer cell lines Cancer Biother. Radiopharm. 20 173 180
24. K. Takashima H. Fujiwara S. Inada K. Atsuji Y. Araki T. Kubota H. Yamagishi 2006 Tracking of green fluorescent protein (GFP)-labeled LAK cells in mice carrying B16 melanoma metastases Anticancer Res. 26 3327 3332
25. T. Takayama T. Sekine M. Makuuchi S. Yamasaki T. Kosuge J. Yamamoto K. Shimada M. Sakamoto S. Hirohashi Y. Ohashi T. Kakizoe 2000 Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial Lancet 356 802 807
26. S. H. Thorne R. S. Negrin C. H. Contag 2006 Synergistic antitumor effects of immune cell-viral biotherapy Science 311 1780 1784
27. M. R. Verneris M. Karami J. Baker A. Jayaswal R. S. Negrin 2004 Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells Blood 103 3065 3072
28. M. R. Verneris M. Kornacker V. Mailander R. S. Negrin 2000 Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis Cancer Immunol. Immunother. 49 335 345
29. P. Wang J. P. Yu S. Y. Gao X. M. An X. B. Ren X. G. Wang W. L. Li 2008 Experimental study on the treatment of intracerebral glioma xenograft with human cytokine-induced killer cells Cell. Immunol. 253 59 65
30. W. Wang J. Epler L. G. Salazar S. R. Riddell 2006 Recognition of breast cancer cells by CD8+ cytotoxic T-cell clones specific for NY-BR-1 Cancer Res. 66 6826 6833
31. R. Yamanaka 2008 Cell- and peptide-based immunotherapeutic approaches for glioma Trends Mol. Med. 14 228 235
32. L. Yang K. Y. Ng K. O. Lillehei 2003 Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma Cancer Control 10 138 147
33. X. J. Yang J. A. Huang W. Lei Y. B. Zhu X. G. Zhang 2006 Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo Ai Zheng 25 1329 1333